STOCK MARKET BSE NSE

Genomic lab to set up for clinical research in city

Published: 17th November 2016 01:32 AM  |   Last Updated: 17th November 2016 07:15 AM   |  A+A-

By Express News Service

CHENNAI: Bangalore-based MedGenome Labs Pvt. Ltd, a genomics-based diagnostics and research services firm and The Madras Medical Mission, Chennai, have collaborated to set up a a state-of-the art genomic laboratory that will aid  clinical and diagnostic research at the hospital premises.


The one-of-a-kind facility aims to be a one-stop solution for genetic testing, research and counselling for diseases including oncology, nephrology, cardiology, metabolic disorders, diabetes, hematology and dermatology. “Prenatal test (non-invasive) will also be available at the centre, which would help would-be parents to know about the genetic health of their baby,” said VL Ramprasad, COO, MedGenome.

MMC, Chennai and MedGenome Labs, Bengaluru, announce setting up of genomic lab| Express


Shedding light on the main aim of the genomic centre, Mullasari Ajit, director, Cardiology, MMM said, “Knowing the genetic factors for certain disease conditions will help in guiding clinicians in better diagnosis and treatment. With medicines becoming morepersonalised/gene based, prescribing drugs based on the pathology may have side effects (killing both harmful and normal cells).


So, it is necessary to create a data base to know the specific gene problem of our population,” he said. “This is not something we have jumped into all of a sudden.We have been working on genomics for that last five years, systematically with different groups in the country,” he added.


The centre which is located in the seventh floor of MMM will offer next-generation sequencing-based genomic solutions at genetic and molecular level. With expensive and high-end testing and lack of awareness among many clinicians posing a challenge to genomic research, Girish Mehta, CEO-India, MedGenome, said “Many doctors aren’t aware of this type of research as they follow a set pattern while diagnosing diseases. But, awareness will increase in coming years and we are doing everything to make the public and doctors aware of genomic research, which will cover exome sequencing, RNA sequencing, and panel sequencing.”


Talking about specific areas in which MMM is planning to collaborate with MedGenome, Shivakumar, Paediatric cardiologist, pointed to the staggering number of heart diseases among infants in Asia (10.3 per cent to 10.4 per cent) as opposed to that of Europe (6.7 per cent to 6.8 per cent).


“Eight out of every 1000 babies born have heart diseases and this might be due to basic gene problem, lifestyle diseases, glucose intolerance among Asian population and so on. Pulmonary arterial hypertension and cardiomyopathy are two diseases which we will be focusing on. Firstly, we will be identifying the basic gene background in our population in order to find new information from observing the genomic sequence; identify new patterns which are unique to our population and leave the data for the future generation to work and identify targeted therapies, ” he said.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

edexworks
flipboard facebook twitter whatsapp